Healio

Cryosurgery, topical 5-fluorouracil treatment may be effective for low-risk skin cancer

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. 6 months after the initial treatment, 90% of Bowen’s ...
Medscape

Randomized, Vehicle-controlled Trials of Topical 5-fluorouracil Therapy for Actinic Keratosis Treatment

Immunotherapy. 2012;4(9):939-945. The percentage of patients achieving complete clearance of their AKs in the 5-FU group was 19, 28.2 and 52.6% in the 1-, 2- and 4-week treatment groups, respectively.
Healio

Combination chemoprevention topical treatment reduces keratinocyte carcinoma incidence

Please provide your email address to receive an email when new articles are posted on . Patients’ odds of having cancer decreased after 1 year of treatment (OR = 0.06). The mean number of cryotherapy ...
Medindia

Extrovis AG and Dr. Reddy's Announce the Launch of the Authorized Generic of Carac (Fluorouracil Cream), 0.5% in the U.S.

Extrovis AG, a global pharmaceutical company focused on research-driven innovation, and Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its ...
Medscape

FDA Safety Labeling Changes: CombiPatch, Efudex, Percodan, and Axert

Sept. 8, 2004 — The U.S. Food and Drug Administration (FDA) approved in June revisions to safety labeling to advise healthcare professionals of the following changes: estradiol/norethindrone patches ...
WAPT

FDA Issues Warning After Skin Cancer Cream Reportedly Killed 5 Dogs

The FDA recently issued a warning that particularly affects those who have pets and use a particular variety of topical cancer medication. According to the FDA, "pets are at risk of illness and death ...
ascopubs.org

Gemcitabine and Paclitaxel Versus Gemcitabine Alone After 5-Fluorouracil, Oxaliplatin, and Irinotecan in Metastatic Pancreatic Adenocarcinoma: A Randomized Phase III PRODIGE 65 ...

Radiographic Progression-Free Survival and Clinical Progression-Free Survival as Potential Surrogates for Overall Survival in Men With Metastatic Hormone-Sensitive Prostate Cancer Patients with ...
manilatimes

Extrovis AG and Dr. Reddy’s announce the launch of the authorized generic of CARAC (fluorouracil cream), 0.5% in the U.S.

Extrovis AG, a global pharmaceutical company focused on research-driven innovation, and Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its ...
Finanznachrichten

Extrovis AG and Dr. Reddy's announce the launch of the authorized generic of CARAC (fluorouracil cream), 0.5% in the U.S.

Extrovis AG and Dr. Reddy's announce the launch of the authorized generic of CARAC (fluorouracil cream), 0.5% in the U.S. Baar, Switzerland; August 14, 2025 Extrovis AG, a global pharmaceutical ...